Cargando…
Structural Remodeling Mechanism of the Toxic Amyloid Fibrillary Mediated by Epigallocatechin-3-gallate
[Image: see text] Numerous therapeutic agents and strategies were designed targeting the therapies of Alzheimer’s disease, but many have been suspended due to their severe clinical side effects (such as encephalopathy) on patients. The attractiveness for small molecules with good biocompatibility is...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2022
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798747/ https://www.ncbi.nlm.nih.gov/pubmed/36591187 http://dx.doi.org/10.1021/acsomega.2c05995 |